InChI=1S/C23H39O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(25)29-20-22(24)21-30-31(26,27)28/h6-7,9-10,12-13,15-16,22,24H,2-5,8,11,14,17-21H2,1H3,(H2,26,27,28)/b7-6-,10-9-,13-12-,16-15-/t22-/m1/s1 |
XBFQFMCUPHZKTI-NZRYSPDRSA-N |
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@@H](O)COP(O)(O)=O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
(via 1-acyl-sn-glycerol 3-phosphate )
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via 1-acyl-sn-glycerol 3-phosphate )
(via monoacylglycerol phosphate )
|
|
(2R)-2-hydroxy-3-(phosphonooxy)propyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
|
1-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phosphate
|
ChEBI
|
1-(5Z,8Z,11Z,14Z)-icosatetraenoyl-sn-glycero-3-phosphate
|
ChEBI
|
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate
|
LIPID MAPS
|
1-arachidonoyl LPA
|
ChEBI
|
1-arachidonoyl lysophosphatidic acid
|
ChEBI
|
LPA(20:4(5Z,8Z,11Z,14Z)/0:0)
|
ChEBI
|
lysophosphatidic acid (20:4(5Z,8Z,11Z,14Z)/0:0)
|
ChEBI
|
PA(20:4(5Z,8Z,11Z,14Z)/0:0)
|
LIPID MAPS
|
PA(20:4/0:0)
|
LIPID MAPS
|